Epigenomes

SJR Rank #3,700H-index: 22SJR: 1.188Best quartile: Q1Open AccessAPC: US$1,810Listed in DOAJ
Journal website: aims, scope and author guidelines
Publisher

Multidisciplinary Digital Publishing Institute (MDPI)

Country

Switzerland

Type

journal

SJR by Edition

2022202500.30.60.91.2

Subject Categories

  • BiochemistryQ1
  • Biochemistry, Genetics and Molecular Biology (miscellaneous)Q1
  • Health, Toxicology and MutagenesisQ1
  • GeneticsQ2

Areas: Biochemistry, Genetics and Molecular Biology · Environmental Science

Most published research topics

Epigenetics and DNA MethylationRNA modifications and cancerGenomics and Chromatin DynamicsCancer-related gene regulationPlant Molecular Biology ResearchHistone Deacetylase Inhibitors ResearchCancer-related molecular mechanisms researchGenetics and Neurodevelopmental DisordersGenetic Syndromes and ImprintingRNA Research and Splicing

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs0306090120

Documents per Year

20222025015304560

Detailed Information

ISSN

2075-4655

SJR Best Quartile

Q1

Region

Western Europe

Citations per Document (2 years)

4.42

References per Document

93.83

Coverage

2017-2025

Scope

Epigenetics, defined as the study of the information carried by the genome that is not encoded by DNA, as well as Epitranscriptomics, defined as the sum of the functionally relevant changes to the transcriptome that do not involve a direct change in the RNA sequence, are two of the most rapidly expanding fields, with clear therapeutic implications. The scope of Epigenomes includes, but is not limited to the following subjects: Functional studies dealing with identification/modus operandi/structure–function relationships or biological activity of methylases, demethylases, acetylases, methyl-binding proteins, or any other type of enzymes involved in DNA, RNA or histone modifications; Studies reporting genome-wide epigenetic status of cells or tissues in specific biologically relevant contexts; Studies describing insights into the role of epigenetics and epitranscriptomics in physical diseases (e.g., cancer, premature aging, allergy, obesity) and psychopathologies (e.g., schizophrenia, autism, addiction); Studies describing the effect of environmental changes on the epigenetic or epitranscriptomic status of cells or tissues; Studies describing the inheritance or fixation of epigenetic characteristics; Description of novel methods to study DNA methylation, histone methylation, RNA modifications, histone acetylation or other types of epigenetic and/or epitranscriptomic modifications in a global fashion; Studies describing novel tools and technologies for epigenetic or epitranscriptomic studies and therapeutics.

Metrics from SCImago Journal Rank 2025. View on SCImago